Skip to main content

New lab for T cell therapy development opens at BC Cancer Agency

An entirely new approach to cancer treatment is one step closer to the clinic with today’s opening of Canada’s most innovative lab for T cell therapy development at the BC Cancer Agency.
Use this image as both the current Page Image and for News listings

​​


The Conconi Family Immunotherapy Lab, located at the BC Cancer Agency in Victoria,  will be the hub of custom immunotherapy treatment production for cancer patients across B.C.​

Immunotherapy is an approach that engages the patient’s immune system to effectively eliminate disease.

The lab’s initial focus will be on Adoptive T Cell Therapy. This is a specific form of immunotherapy that amplifies the power of T cells—immune cells responsible for destroying viruses and tumors—extracted from an individual cancer patient. In a highly selective process, scientists identify the T cells already attempting to destroy the cancer and multiply them by the thousands in the lab. The end product is a supercharged batch of a patient’s own T cells that can be delivered through an IV infusion. 

Read​ more here​.

Clinical trials; BC Cancer Agency
Research
SOURCE: New lab for T cell therapy development opens at BC Cancer Agency ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer. All Rights Reserved.

    Copyright © 2019 Provincial Health Services Authority